临床试验,挑战和改变基于TCR的治疗方法用于血液恶性瘤的临床试验
Melinda A Biernacki1, Marie Bleakley1,2
1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Expert review of hematology
|December 12, 2024
概括
通过T细胞受体工程的T细胞 (TCR-T) 显示出通过识别细胞内和表面蛋白质来治疗血液癌症的前景. 未来的试验将专注于优化目标和增强TCR-T功能,以获得更广泛的临床应用.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法 细胞疗法
背景情况:
- 经T细胞受体工程的T细胞 (TCR-T) 是一种针对血液性恶性瘤的新型免疫疗法.
- 通过识别细胞内和细胞表面的点,TCR-T细胞比仿真抗原受体T细胞 (CAR-T) 具有优势.
- 自然的T细胞受体信号机制增强了TCR-T的灵敏度.
研究的目的:
- 审查TCR-T用于血液恶性瘤的早期临床试验结果.
- 讨论TCR-T疗法的挑战和创新.
- 为TCR-T在治疗血液癌症中的未来提供专家意见.
主要方法:
- 审查涉及TCR-T的早期临床试验.
- 分析诸如目标识别,CD4+T细胞帮助和瘤抑制等挑战.
- 突出最近的创新和TCR-T发展的未来方向.
主要成果:
- 越来越多的针对各种抗原的TCR-T疗法正在临床试验中.
- 在TCR-T治疗中的挑战包括标选择,T细胞的帮助和克服瘤抑制.
- 正在开发创新来提高TCR-T的有效性和克服耐药性.
结论:
- 对于血液性恶性瘤,TCR-T疗法具有显著的前景,预计将进行后期试验和批准.
- 抗原发现和TCR-T设计的进步,包括基因编辑和混合受体,将扩大它们的临床实用性.
- 优化TCR-T功能和克服瘤诱导的抑制是实现其全部治疗潜力的关键.
更多相关视频
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.3K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
460
相关概念视频
01:27Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
01:22Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K